These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 18367459

  • 1. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS, Prado GV, Costa SF, Grinbaum RS, Levin AS.
    J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
    Deris ZZ, Harun A, Shafei MN, Rahman RA, Johari MR.
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.
    Prates CG, Martins AF, Superti SV, Lopes FS, Ramos F, Cantarelli VV, Zavascki AP.
    Epidemiol Infect; 2011 Mar; 139(3):411-8. PubMed ID: 20513254
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mortality risk factors of Acinetobacter baumannii bacteraemia.
    Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YA, Song YG, Yong D, Lee K, Kim JM.
    Intern Med J; 2005 Oct; 35(10):599-603. PubMed ID: 16207259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
    Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW.
    J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Acinetobacter infections.
    Michalopoulos A, Falagas ME.
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
    Metan G, Sariguzel F, Sumerkan B.
    Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
    [Abstract] [Full Text] [Related]

  • 14. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC.
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [Abstract] [Full Text] [Related]

  • 15. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H.
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W, Wang R, Chai D, Li Z, Pei F.
    Int J Antimicrob Agents; 2006 Nov; 28(5):454-6. PubMed ID: 16987639
    [Abstract] [Full Text] [Related]

  • 17. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
    Kim YA, Choi JY, Kim CK, Kim CO, Kim MS, Choi SH, Chin BS, Han SH, Lee HS, Choi HK, Jeoung SJ, Song YG, Yum JH, Yong D, Lee K, Kim JM.
    Scand J Infect Dis; 2008 Nov; 40(3):234-40. PubMed ID: 17852898
    [Abstract] [Full Text] [Related]

  • 18. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
    del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D, Molina F, Villanueva R, Cisneros JM, Bou G.
    Clin Microbiol Infect; 2005 Jul; 11(7):540-6. PubMed ID: 15966971
    [Abstract] [Full Text] [Related]

  • 19. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S, Tonsawan P.
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL, Wan YF, Zhou LY, Ye ML, Liu S, Xu CQ, He YQ, Chen JH.
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.